Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer

AI Briefing

• – Novocure's Phase 2 PANOVA-4 trial shows positive results for metastatic pancreatic cancer treatment
• – The trial met its primary endpoint, achieving a statistically significant improvement in disease control rate
• – Treatment combination of Tumor Treating Fields and atezolizumab showed promising results